Clinical Trial Search Results

598 studies were found about Treatment Research, Treatment-Experienced Patients
Filter Results: All Studies Studies seeking new volunteers Studies with results

Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients

Condition: Acquired Immune Deficiency Syndrome; HIV Infections

NCT ID: NCT00872417

Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment

Condition: HIV Infections

NCT ID: NCT00011128

Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)

Condition: HIV; HIV Infections

NCT ID: NCT00928187

A Study on the Safety and Anti-HIV Activity of HE2000 in HIV-Infected Patients on Salvage Therapy

Condition: HIV Infections

NCT ID: NCT00002422

Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-Infected Patients in Virological Failure.

Condition: HIV Infections

NCT ID: NCT00196625

Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00523211

Efficacy and Safety of Single Versus Double Ritonavir-Boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens

Condition: HIV Infection; HIV Infections

NCT ID: NCT00886990

Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00551330

TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients

Condition: HIV Infection

NCT ID: NCT00110877

Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*

Condition: HIV Infections

NCT ID: NCT00511368

Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia

Condition: HIV Infection; Hemophilia A

NCT ID: NCT00797381

Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens

Condition: HIV Infections

NCT ID: NCT00627055

Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)

Condition: HIV Infections

NCT ID: NCT00615563

Optimizing Treatment for Treatment-Experienced, HIV-infected People

Condition: HIV Infections

NCT ID: NCT00537394

Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment

Condition: HIV Infections

NCT ID: NCT00006591

Genotyping Directed Salvage Therapy in Children Who Have Failed Dual NRTIs

Condition: HIV Infections

NCT ID: NCT00477308

Europe-Africa Research Network for Evaluation of Second-line Therapy

Condition: Human Immunodeficiency Virus; HIV

NCT ID: NCT00988039

A PK and Salvage Study for Children With HIV-infection

Condition: HIV Infections

NCT ID: NCT00476359

TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00896051

Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00474370

TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1

Condition: HIV Infections

NCT ID: NCT00089700

High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease

Condition: HIV; AIDS

NCT ID: NCT00247143

Safety and Efficacy of Switching a Stable Combined Antiretroviral Therapeutic Regimen to Atazanavir With Ritonavir Plus Lamivudine in Treatment Experienced HIV Positive Patients With Full and Stable Virological Suppression

Condition: Human Immunodeficiency Virus

NCT ID: NCT01599364

A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.

Condition: HIV Infections

NCT ID: NCT00976950

A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy

Condition: HIV Infections

NCT ID: NCT01026727

A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen

Condition: HIV Infections

NCT ID: NCT00931463

TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Children and Adolescents

Condition: HIV Infections; HIV-1

NCT ID: NCT00980538

A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine

Condition: Toxoplasmosis, Cerebral; HIV Infections

NCT ID: NCT00001994

QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection

Condition: HIV Infections

NCT ID: NCT00232908

Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00082498

BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.

Condition: HIV Infections

NCT ID: NCT00326963

Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults

Condition: HIV Infections

NCT ID: NCT00376935

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Condition: HIV; Tuberculosis

NCT ID: NCT01663168

Safety and Effectiveness of Raltegravir (MK-0518) in Treatment-Experienced, HIV-Infected Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00485264

Efficacy and Safety of Raltegravir (RAL) in Treatment-experienced HIV-1 Infected Adult Chinese Patients

Condition: HIV

NCT ID: NCT01201239

Once Daily 3TC, Efavirenz and ddI for HIV Infection

Condition: HIV Infection; AIDS

NCT ID: NCT00214435

A Proof of Concept Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics of the CCR5 Antagonist TBR 652 in HIV 1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients

Condition: HIV-1 Infection

NCT ID: NCT01092104

Phase III PEG-Intron in HIV-Infected Patients (Study P00738)(COMPLETED)

Condition: HIV Infections; AIDS

NCT ID: NCT00035360

Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

Condition: HIV Infection

NCT ID: NCT00297076

Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects

Condition: HIV Infection

NCT ID: NCT00197197

HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain

Condition: HIV Infections

NCT ID: NCT00685191

Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)

Condition: HIV Infection

NCT ID: NCT00707733

Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)

Condition: HIV Infection

NCT ID: NCT00708162

Non-Interventional Study Of Celsentri® In Treatment Experienced Patients With CCR5-Tropic HIV-Infection

Condition: HIV-1

NCT ID: NCT00850395

Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients

Condition: HIV Infections

NCT ID: NCT00504452

Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance

Condition: HIV Infections

NCT ID: NCT00046033

Early Access to TMC114/r and Other AVT for Treatment-naive or Early Treatment Experienced in HIV-1 Patients

Condition: HIV-1

NCT ID: NCT01702090

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

Condition: HIV

NCT ID: NCT01255371

Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced Population

Condition: HIV Infections

NCT ID: NCT00614302

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients

Condition: Human Immunodeficiency Virus (HIV) Infection

NCT ID: NCT01422330

Data Analysis for 04-C-0234 Tenofovir Disoproxil Fumarate Salvage Therapy in HIV-Infected Children and a Study of Its Effect on Bone Metabolism

Condition: HIV-Infected Children

NCT ID: NCT01361165

The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs.

Condition: HIV-1

NCT ID: NCT00354627

Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients

Condition: HIV Infections; Hepatitis C, Chronic; Treatment Failure

NCT ID: NCT00221650

Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected Antiretroviral Treatment Experienced Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00766597

An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.

Condition: HIV Infection

NCT ID: NCT00081588

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Condition: HIV Infections; Human Immunodeficiency Virus

NCT ID: NCT00299897

HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy

Condition: HIV-1 Infection

NCT ID: NCT00709397

Effect of Tenofovir DF on Bone Metabolism in Children

Condition: HIV Infections

NCT ID: NCT00088309

A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy

Condition: Cytomegalovirus Retinitis; HIV Infections

NCT ID: NCT00000673

A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00113412

TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.

Condition: HIV Infections

NCT ID: NCT00245739

A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure

Condition: Cytomegalovirus Retinitis; HIV Infections

NCT ID: NCT00000691

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects

Condition: Human Immunodeficiency Virus Infection

NCT ID: NCT01738555

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.

Condition: Human Immunodeficiency Virus Infection

NCT ID: NCT01737359

A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00488059

Can Resistance Enhance Selection of Treatment? (CREST)

Condition: HIV Infection

NCT ID: NCT00262717

Sequential HIV Therapy in Treatment Resistant HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00128908

A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)

Condition: Human Immunodeficiency Virus - Type 1

NCT ID: NCT00524368

Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects

Condition: HIV Infections

NCT ID: NCT00121979

Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals

Condition: HIV Infections

NCT ID: NCT00034866

Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.

Condition: HIV; HIV-1; Human Immunodeficiency Virus

NCT ID: NCT00298350

Adding New Drugs for HIV Infected Patients Failing Current Therapy

Condition: HIV Infections

NCT ID: NCT00031044

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

Condition: HIV Infections

NCT ID: NCT00126880

Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection

Condition: HIV Infections

NCT ID: NCT00612898

A Long Term Safety Study of Apricitabine in HIV-infected Patients

Condition: HIV Infections

NCT ID: NCT00686270

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Condition: HIV

NCT ID: NCT01605084

Study of Options for Second-Line Effective Combination Therapy (SELECT)

Condition: HIV-1 Infection

NCT ID: NCT01352715

A Prospective Cohort of Children With HIV Infection

Condition: HIV Infections

NCT ID: NCT00476606

DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects

Condition: HIV

NCT ID: NCT01423812

A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection

Condition: HIV Infections

NCT ID: NCT00038272

Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PI

Condition: HIV Infections

NCT ID: NCT00517192

Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor

Condition: HIV Infections

NCT ID: NCT00041769

Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children

Condition: HIV Infections

NCT ID: NCT01504841

A Pediatric Trial to Provide Dose Recommendation of TMC114/Rtv in HIV-1 Infected Children and Adolescents

Condition: HIV-1; HIV Infections

NCT ID: NCT00355524

Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients

Condition: HIV Infection; HIV Infections

NCT ID: NCT00943540

Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients

Condition: HIV Infections

NCT ID: NCT00752037

Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

Condition: HIV Infection

NCT ID: NCT00197145

An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children

Condition: Human Immunodeficiency Virus (HIV)

NCT ID: NCT00791700

TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents

Condition: HIV-1

NCT ID: NCT00665847

TMC114-TiDP29-C228 - A Safety Study to Evaluate the Antiviral Activity of Darunavir (DRV) in Combination With Ritonavir (Rtv) in HIV 1 Infected Children From 3 Years to Below 6 Years of Age

Condition: HIV Infections

NCT ID: NCT00919854

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)

Condition: Chronic Hepatitis C

NCT ID: NCT01513941

HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections

Condition: Human Immunodeficiency Virus-1

NCT ID: NCT01384734

Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00089466

Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs

Condition: HIV Infections; Human Immunodeficiency Virus

NCT ID: NCT00300573

Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241 AM3)(COMPLETED)

Condition: HIV Infections

NCT ID: NCT00632073

Vicriviroc (SCH 417690) Treatment Protocol in HIV-Infected Subjects: A Rollover Study for ACTG Protocol A5211 (Study P04100AM4)(COMPLETED)

Condition: HIV Infections

NCT ID: NCT00686829

Second-line Therapy

Condition: Treatment Failure of Second-line ART in Asian HIV-infected Children

NCT ID: NCT01788891

Ritonavir-boosted Lopinavir Monotherapy

Condition: HIV

NCT ID: NCT01002898

Telephone Support to Improve Adherence to Anti-HIV Medications

Condition: HIV Infections

NCT ID: NCT00988442

Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy

Condition: HIV Infections

NCT ID: NCT00352053

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Condition: HIV Infections

NCT ID: NCT00102206

Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir

Condition: HIV Infections; Treatment Experienced

NCT ID: NCT00976404

Structured Treatment Interruption for HIV Patients With Virologic Failure

Condition: HIV

NCT ID: NCT00188851

Bone and Body Comp: A Sub Study of the SECOND-LINE Study

Condition: HIV

NCT ID: NCT01513122

A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure

Condition: HIV-1 Infection

NCT ID: NCT01641367

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects

Condition: Chronic Hepatitis C; Human Immunodeficiency Virus

NCT ID: NCT01783678

Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children

Condition: This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy.

NCT ID: NCT01225406

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00098748

A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience

Condition: HIV Infections

NCT ID: NCT00487188

Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy (0518-023)(COMPLETED)

Condition: HIV Infections

NCT ID: NCT00377065

Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay

Condition: HIV Infections

NCT ID: NCT00496782

INROADS, Abbreviated Title: Intelence aNd PRezista Once A Day Study

Condition: HIV

NCT ID: NCT01199939

An Observational Study of People Who Have Recently Been Infected With HIV

Condition: HIV Infections

NCT ID: NCT00103961

Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen

Condition: HIV; Hypercholesterolemia; Dyslipidemia

NCT ID: NCT01705873

Emergency Use Program for HTE HIV+ Patients Who Need Tipranavir Treatment

Condition: HIV Infections

NCT ID: NCT00062660

A Long Term, Safety Study of Apricitabine in HIV-infected Subjects

Condition: HIV Infection

NCT ID: NCT00367952

Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002415

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

Condition: HIV Infections

NCT ID: NCT00089492

WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.

Condition: HIV Infections

NCT ID: NCT00233883

CSP #512 - Options in Management With Anti-Retrovirals

Condition: AIDS; HIV Infections

NCT ID: NCT00050089

A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

Condition: HIV Infections; HIV-Associated Lipodystrophy Syndrome; HIV Lipodystrophy Syndrome; Lipodystrophy; Dyslipidemia; Osteoporosis; Osteopenia

NCT ID: NCT00069004

Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome

Condition: HIV (Human Immunodeficiency Virus); Metabolic Syndrome; HIV Infections

NCT ID: NCT00857298

Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection; HIV-1 Infection

NCT ID: NCT00481390

A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure

Condition: HIV Infections

NCT ID: NCT00000918

Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy

Condition: HIV; HIV Infections

NCT ID: NCT00959361

Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1

Condition: HIV

NCT ID: NCT00784147

Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART

Condition: HIV Seropositivity; HIV Infection

NCT ID: NCT00035581

Seroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daily Valacyclovir in the Reduction of HSV-2 Recurrence and Viral Shedding

Condition: HSV-2; HIV; HIV Infections

NCT ID: NCT00803543

A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women

Condition: HIV; HIV Infections; Pregnancy

NCT ID: NCT00855335

Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

Condition: HIV-Associated Lipodystrophy; HIV Infections

NCT ID: NCT00126308

Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir

Condition: HIV Infections; AIDS Virus; Human Immunodeficiency Virus; Acquired Immunodeficiency Syndrome Virus

NCT ID: NCT00458302

Statin Therapy to Improve Atherosclerosis in HIV Patients

Condition: Cardiovascular Disease; HIV; Atherosclerosis; Inflammation; Statins, HMG-CoA; HIV Infections

NCT ID: NCT00965185

Profile of HIV Seropositive Patients

Condition: HIV Infection; HIV Infections

NCT ID: NCT00981279

Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients

Condition: HIV-Associated Lipodystrophy Syndrome; HIV Infections

NCT ID: NCT00148850

Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV

Condition: HIV; HIV Infections

NCT ID: NCT00842634

Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1

Condition: HIV-1; HIV Infections

NCT ID: NCT00807443

Pharmacotherapy for HIV Infected Patients With Alcohol Problems

Condition: HIV Infection; Heavy Alcoholic Consumption; HIV Infections

NCT ID: NCT00854230

Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals

Condition: HIV Infection; HIV Infections

NCT ID: NCT00870792

Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome

Condition: HIV Infections; Cardiovascular Disease; Insulin Resistance; HIV Lipodystrophy; The Metabolic Syndrome

NCT ID: NCT00656851

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Condition: Accelerated Phase Chronic Myelogenous Leukemia; Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Acute Undifferentiated Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Grade III Lymphomatoid Granulomatosis; Adult Langerhans Cell Histiocytosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Aggressive NK-cell Leukemia; AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Diffuse Small Cleaved Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Lymphoblastic Lymphoma; AIDS-related Malignancies; AIDS-related Small Noncleaved Cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Chronic Eosinophilic Leukemia; Chronic Myelomonocytic Leukemia; Chronic Neutrophilic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Clear Cell Renal Cell Carcinoma; Cutaneous B-cell Non-Hodgkin Lymphoma; de Novo Myelodysplastic Syndromes; Essential Thrombocythemia; Extramedullary Plasmacytoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; HIV Infection; HIV-associated Hodgkin Lymphoma; Intraocular Lymphoma; Isolated Plasmacytoma of Bone; Light Chain Deposition Disease; Mast Cell Leukemia; Myelodysplastic Syndrome With Isolated Del(5q); Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Myeloid/NK-cell Acute Leukemia; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Osteolytic Lesions of Multiple Myeloma; Peripheral T-cell Lymphoma; Plasma Cell Neoplasm; Polycythemia Vera; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Primary Myelofibrosis; Primary Systemic Amyloidosis; Progressive Hairy Cell Leukemia, Initial Treatment; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Renal Cell Cancer; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Stage IV Renal Cell Cancer; T-cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific; Waldenström Macroglobulinemia

NCT ID: NCT00890747

Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

Condition: HIV-Associated Lipodystrophy Syndrome; Insulin Resistance; HIV Infections; Metabolic Syndrome X; Body Weight Changes

NCT ID: NCT00130286

Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients

Condition: HIV Infection; HIV Infections

NCT ID: NCT01044654

A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects

Condition: HIV-1 Infection; HIV Infections

NCT ID: NCT00833781

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

Condition: HIV/HCV Co-infection; HIV Infections

NCT ID: NCT00866021

A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients

Condition: HIV-1 Infection; HIV Infections

NCT ID: NCT01000818

Exercise and Pioglitazone for HIV-Metabolic Syndromes

Condition: HIV Infections; Type 2 Diabetes; Obesity; HIV; AIDS; Cardiovascular Disease; Lipodystrophy

NCT ID: NCT00639457

Measurement of Adherence to ART in HIV-Infected Children in Uganda (The CHARTA Study)

Condition: HIV; HIV Infections

NCT ID: NCT00868257

Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients

Condition: HIV; Hyperlipidemia; HIV Infections

NCT ID: NCT00843661

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01440569

Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01533259

Phase 3b Open Label Study to Evaluate Switching From Regimens Consisting of a Non-nucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV 1 Infected Patients

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01495702

Phase 3b Open Label Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV 1 Infected Patients

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01475838

Study of Bone Disease in Older HIV-infected Adults

Condition: Osteopenia; Osteoporosis; HIV Infection; Aging; HIV Infections

NCT ID: NCT00935935

Treatment De-Intensification and Residual HIV-1 in Youth

Condition: HIV-1; HIV Infections

NCT ID: NCT00867854

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01363011

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

Condition: HIV Infections

NCT ID: NCT00039741

Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules

Condition: HIV1 Infection; HIV Infections

NCT ID: NCT00937729

Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients

Condition: Human Immunodeficiency Viruses; Kidney Failure; HIV Infections

NCT ID: NCT00551655

Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection.

Condition: HIV-1 Infection; HIV Infections

NCT ID: NCT00849160

PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon

Condition: Chronic Hepatitis C Infection in HIV-Infected Persons; HIV Infections

NCT ID: NCT00215891

HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy

Condition: Chronic Hepatitis C Infection in HIV Infected Persons; HIV Infections

NCT ID: NCT00215839

A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years

Condition: HIV Infections

NCT ID: NCT00006509

HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00056758

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00052182

Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection

Condition: HIV Infections

NCT ID: NCT00125099

Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy

Condition: HIV Infections

NCT ID: NCT00559416

Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV

Condition: HIV Infections

NCT ID: NCT00016783

Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00117429

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

Condition: HIV Infections

NCT ID: NCT00107549

Effect of Raltegravir on Endothelial Function in HIV-Infected Patients

Condition: HIV Infection; Inflammation; Cardiovascular Disease; HIV Infections

NCT ID: NCT00843713

Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension

Condition: HIV Infection; Pulmonary Hypertension; Endothelial Function; HIV Infections

NCT ID: NCT00845013

Computer-Assisted Adherence Program for Patients Taking Anti-HIV Drugs

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00051766

Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir

Condition: HIV Infections

NCT ID: NCT00006326

Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140

Condition: HIV Infection

NCT ID: NCT00123890

Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens

Condition: Pediatric HIV; HIV Infections

NCT ID: NCT00940771

Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00080106

Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients

Condition: HIV Infection

NCT ID: NCT00219362

Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol

Condition: HIV Infections; HIV Positive; Pregnant Women

NCT ID: NCT00639145

Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART)

Condition: Acquired Immune Deficiency Syndrome Virus; HIV Infections

NCT ID: NCT00974454

Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels

Condition: HIV Infections

NCT ID: NCT00987948

LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)

Condition: HIV Infections; Diffuse Large B Cell Lymphoma

NCT ID: NCT00466258

Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs

Condition: HIV Infections; Peripheral Nervous System Disease

NCT ID: NCT00017771

Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1

Condition: HIV Infections

NCT ID: NCT00476671

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Condition: HIV-Associated Lipodystrophy Syndrome; Cardiovascular Disease

NCT ID: NCT00192660

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

Condition: HIV Infections

NCT ID: NCT00006604

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Condition: HIV Infections

NCT ID: NCT00014937

Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine (ISS T-002)

Condition: HIV Infections

NCT ID: NCT00751595

Effectiveness of Nucleoside Supplementation and Substituting Tenofovir Disoproxil Fumarate for Other Drugs in Anti-HIV Regimens in Reversing Fat Loss in HIV Infected Adults

Condition: HIV Infections; Lipodystrophy; Metabolic Diseases; Nutrition Disorders

NCT ID: NCT00119379

Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure

Condition: HIV Infections; AIDS; Lopinavir; Treatment Failure

NCT ID: NCT01189695

Study Evaluating Vaccine in Adults With HIV

Condition: HIV Infections

NCT ID: NCT00195234

Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV

Condition: HIV Infections

NCT ID: NCT00056797

Study Evaluating Vaccine in Adults With HIV

Condition: HIV Infections

NCT ID: NCT00195312

The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV

Condition: HIV Infections

NCT ID: NCT00004735

Effect of Maraviroc on Endothelial Function in HIV-Infected Patients

Condition: HIV Infection; Cardiovascular Disease; Inflammation; HIV Infections

NCT ID: NCT00844519

Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy

Condition: HIV Infections

NCT ID: NCT00038259

Switch From Combivir to Truvada - Mitochondrial Effects

Condition: HIV; HIV Infections

NCT ID: NCT00960622

The First Failure Study

Condition: HIV; HIV Infections

NCT ID: NCT01118871

Pilot Study of a Raltegravir Based NRTI Sparing Regimen

Condition: Acquired Immune Deficiency Syndrome; AIDS; Human Immunodeficiency Virus; HIV Infections

NCT ID: NCT00814879

Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding

Condition: HIV Infections

NCT ID: NCT00074412

A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity

Condition: Obesity; HIV Infections

NCT ID: NCT00267527

"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects

Condition: HIV Infection

NCT ID: NCT00114933

Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00946595

Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load

Condition: HIV Infections

NCT ID: NCT00454337

Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00100633

Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults

Condition: HIV Infections

NCT ID: NCT00110578

Safety and Acceptability of Carraguard® in HIV Positive Women and Men

Condition: HIV Infections

NCT ID: NCT00213005

HIV - Monotherapy in Switzerland (MOST-ch)

Condition: HIV Infections

NCT ID: NCT00531986

Prospective Observational Epidemiologic Study of Maraviroc's Safety

Condition: Human Immunodeficiency Virus

NCT ID: NCT00665561

TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy

Condition: Lipodystrophy; HIV Infections

NCT ID: NCT00608023

Bioequivalence Study of Didanosine in Children Treated for HIV

Condition: HIV Infections

NCT ID: NCT00668356

Effects of HIV and Hepatitis C Virus on the Brain

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00494936

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00058734

Phase II Study of AGS‑004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV

Condition: HIV Infections

NCT ID: NCT00672191

Metabolic Abnormalities - HIV Infected and Uninfected Males

Condition: HIV Infections

NCT ID: NCT00260936

Immune and Viral Outcomes of HIV-1 Therapy Interruption

Condition: HIV Infections

NCT ID: NCT00051818

Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons

Condition: Tuberculosis; Latent Tuberculosis Infection; HIV Infections

NCT ID: NCT00463086

Fanconi Syndrome Due to ARVs in HIV-Infected Persons

Condition: HIV Infections; Fanconi Syndrome; Kidney Disease; Renal Impairment

NCT ID: NCT00499187

Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus

Condition: HIV Infections

NCT ID: NCT00102934

Enhancing Oral Health Care Use by HIV Positive Individuals

Condition: Oral Hygiene; HIV Infections; Mouth Diseases

NCT ID: NCT00444977

Acupuncture/Moxibustion for Peripheral Neuropathy in HIV

Condition: Peripheral Neuropathies; HIV Infections

NCT ID: NCT00317291

Marijuana for HIV-Related Peripheral Neuropathy

Condition: Peripheral Nervous System Diseases; HIV Infections

NCT ID: NCT00046722

Valproic Acid and Its Effects on HIV Latent Reservoirs

Condition: HIV Infections

NCT ID: NCT00289952

Kaletra Monotherapy in HIV/HCV Co-infected Subjects

Condition: HIV Infections

NCT ID: NCT00508222

Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients

Condition: HIV Infection

NCT ID: NCT00420355

Maraviroc in Immunological Non-Responder (INR) HIV-1-infected Subjects

Condition: HIV Infections

NCT ID: NCT00884858

Correlation Between Intestinal Parasites and Serum Level of Eosinophils and IgE in Individuals With HIV or AIDS

Condition: HIV Infections

NCT ID: NCT00546689

MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection

Condition: HIV Infections

NCT ID: NCT00614458

A Randomized, Dose-Ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects

Condition: HIV Infections

NCT ID: NCT00215852

Oral Human Papillomavirus Infection in HIV-Infected Men

Condition: Papillomavirus Infections; HIV Infections

NCT ID: NCT00421486

TH9507 in Patients With HIV-Associated Lipodystrophy

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00123253

Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00287677

A Comparison of Two Anti-HIV Treatment Plans

Condition: HIV Infections

NCT ID: NCT00005915

Kidney and Liver Transplantation in People With HIV

Condition: HIV Infections; Kidney Disease; Liver Disease

NCT ID: NCT00074386

Pioglitazone to Treat Fatty Liver in People With HIV Infection

Condition: HIV Infections; Hepatic Steatosis; Insulin Resistance

NCT ID: NCT00441272

Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression

Condition: HIV Infections

NCT ID: NCT00554398

Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels

Condition: Atherosclerosis; HIV Infections

NCT ID: NCT00143624

Lifestyle Modification and Metformin Use in the Treatment of HIV

Condition: HIV Infections; Metabolic Syndrome X

NCT ID: NCT00399360

HIV in the Female Genital Tract

Condition: HIV Infections

NCT ID: NCT00067106

Understanding the Increased Risk of Cardiovascular Disease in People With HIV

Condition: HIV Infections

NCT ID: NCT00577681

HIV and Cardiovascular Risk

Condition: HIV Infections; Cardiovascular Disease

NCT ID: NCT00465426

Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy

Condition: HIV Infections; Lipoatrophy

NCT ID: NCT00312832

Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth

Condition: HIV Infections; H1N1 Influenza Virus

NCT ID: NCT00992836

HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00043641

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

Condition: HIV Infections

NCT ID: NCT00028366

A Phase 2 Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00445146

IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients

Condition: HIV Infections

NCT ID: NCT00935480

Pravastatin for Hyperlipidaemia in HIV.

Condition: HIV Infections; Lipid Metabolism; Glucose Metabolism; Metabolic Abnormality; Lipodystrophy; Cardiovascular Disease

NCT ID: NCT00227500

Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00140751

Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir

Condition: HIV Infections

NCT ID: NCT00001133

Growth Hormone to Increase Immune Function in People With HIV

Condition: HIV Infections

NCT ID: NCT00071240

Evaluating Immune Function Tests in People With HIV

Condition: HIV Infections

NCT ID: NCT00067795

Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV

Condition: HIV Infections

NCT ID: NCT00995241

Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study

Condition: HIV Infection

NCT ID: NCT01038401

Androgen Effects in HIV-infected Women

Condition: HIV Infection

NCT ID: NCT00095212

Physiologic Growth Hormone Effects in HIV Lipodystrophy

Condition: AIDS; HIV Infections

NCT ID: NCT00100698

Enhancing Communication and HIV Outcomes

Condition: HIV Infections

NCT ID: NCT00675610

Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy

Condition: HIV Infections

NCT ID: NCT00757250

Predictors of Drug Hypersensitivity in HIV Infected Subjects

Condition: HIV Infections; Hypersensitivity

NCT ID: NCT00168220

Trial of Zinc and HIV Progression in Children

Condition: HIV Infections

NCT ID: NCT00446758

Mechanisms of Lipodystrophy in HIV-Infected Pateints

Condition: HIV Infections

NCT ID: NCT00457665

Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men

Condition: Anus Neoplasms; HIV Infections

NCT ID: NCT00428285

Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.

Condition: HIV Infections

NCT ID: NCT00158821

Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136

Condition: HIV Infections

NCT ID: NCT00421551

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00437684

Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses

Condition: HIV Infections

NCT ID: NCT00460382

Management of Hepatitis C in HIV-Infected and Uninfected IDUs

Condition: Hepatitis C Virus; HIV Infections

NCT ID: NCT00496912

Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00662545

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

Condition: HIV Infections

NCT ID: NCT00307502

Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults

Condition: Insulin Resistance; HIV Infections

NCT ID: NCT00109746

Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women

Condition: Malaria; HIV Infections

NCT ID: NCT00993031

Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women

Condition: HIV Infections

NCT ID: NCT00745368

Endothelial Dysfunction as a Risk Factor in HIV Study

Condition: HIV Infections

NCT ID: NCT00039663

Reducing HIV Risks in African American Teens

Condition: HIV Infections

NCT ID: NCT00963963

A Mindfulness Based Approach to HIV Treatment Side Effects

Condition: HIV Infections

NCT ID: NCT00312936

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Condition: HIV Infections

NCT ID: NCT00825929

Intermittent vs. Continuous HAART to Treat Chronic HIV Infection

Condition: HIV Infection

NCT ID: NCT00025909

Pravastatin and Protease Inhibitors in HIV-Infected Patients

Condition: HIV Infection; Hypercholesterolemia

NCT ID: NCT00221754

A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00299338

Pain and Sensory Changes Assessment in HIV+ Patients

Condition: HIV Infections

NCT ID: NCT00422695

Zidovudine Levels in HIV Infected Patients Being Treated for HCV

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00059358

The Detection of Drug-Resistant HIV-1 in Taiwan

Condition: HIV Infections

NCT ID: NCT00690001

Hepatitis B Vaccination (HBV) in HIV Infected Children

Condition: HIV Infections

NCT ID: NCT00886964

Epoetin Alfa for HIV-Associated Neuropathy Trial

Condition: HIV Infections; Neuropathy

NCT ID: NCT00528593

The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk

Condition: HIV Infection; Cardiovascular Disease; Inflammation

NCT ID: NCT01333644

Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine

Condition: HIV Infections; Hypertension

NCT ID: NCT00564057

Pilot Study of Text Message Reminders to Improve HIV Medication Adherence in Botswana

Condition: HIV Infections

NCT ID: NCT01001741

Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients

Condition: HIV Infections; Malaria

NCT ID: NCT00421473

Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda

Condition: HIV Infections

NCT ID: NCT00674921

The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00119769

Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status

Condition: HIV Infections

NCT ID: NCT01040091

Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor

Condition: HIV Infection

NCT ID: NCT00001826

Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00069498

Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r

Condition: HIV Infections

NCT ID: NCT00476502

Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study Participants

Condition: HIV Infections

NCT ID: NCT00386035

Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs

Condition: HIV Infection

NCT ID: NCT00006494

Safety Study of Elvucitabine in HIV-1 Subjects

Condition: HIV Infections

NCT ID: NCT00405249

A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00397566

Effect of Atazanavir on Endothelial Function in HIV-Infected Patients

Condition: HIV Infections; Dyslipidemia

NCT ID: NCT00447070

Influence of Pravastatin on Carotid Artery Structure and Function in HIV-Infected Patients Under Antiretroviral Therapy

Condition: HIV Infection; Carotid Atherosclerosis; Dyslipidemia

NCT ID: NCT00147797

Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults

Condition: HIV Infections; Malaria

NCT ID: NCT00869700

3TC or No 3TC for HIV With 3TC Resistance

Condition: HIV Infections

NCT ID: NCT00143728

Effects of Changing HIV Therapy at Lower Versus Higher Viral Loads

Condition: HIV Infections

NCT ID: NCT00036465

Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus

Condition: HIV Infection

NCT ID: NCT00321438

Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects

Condition: HIV Infection

NCT ID: NCT00091741

Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00050921

A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly

Condition: HIV Infections

NCT ID: NCT00001129

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

Condition: HIV Infections

NCT ID: NCT00038519

Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C

Condition: HIV Infections; Hepatitis C, Chronic

NCT ID: NCT00122616

Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00316589

Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut

Condition: HIV Infections

NCT ID: NCT00884793

Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.

Condition: HIV Infections

NCT ID: NCT00148824

Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC)

Condition: HIV Infection

NCT ID: NCT00918840

Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens

Condition: HIV Infections

NCT ID: NCT00129194

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00086359

Interleukin-2 Plus Antiretroviral Therapy for HIV-Infected Patients With Low CD4+ Counts (SILCAAT Study)

Condition: HIV Infection

NCT ID: NCT00013611

Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy

Condition: HIV Infection

NCT ID: NCT00234962

Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients

Condition: HIV Infections

NCT ID: NCT00106379

Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)

Condition: HIV Infections

NCT ID: NCT00573001

Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery

Condition: HIV Infections

NCT ID: NCT00562510

Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis B; Hepatitis C

NCT ID: NCT00051077

Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS

Condition: Anxiety Disorders; HIV Infections

NCT ID: NCT00887679

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

Condition: HIV Infections

NCT ID: NCT00038532

A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients

Condition: HIV Infections

NCT ID: NCT00541463

Immunologic Control of Drug Resistant HIV

Condition: HIV Infections

NCT ID: NCT00053404

An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals

Condition: HIV Infections; HCV

NCT ID: NCT00489385

Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

Condition: Liver Cirrhosis; Hepatitis C Virus; HIV Infection

NCT ID: NCT01006031

Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients

Condition: Hepatitis B; HIV Infections

NCT ID: NCT00391638

Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00207948

Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients

Condition: HIV Infections; Lipoatrophy

NCT ID: NCT00978237

Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy

Condition: HIV Infections; Dyslipidemia; Hyperlipidemia; Hypercholesterolemia; Hypertriglyceridemia

NCT ID: NCT00109603

Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00075907

Switch From Tenofovir to Raltegravir for Low Bone Mineral Density

Condition: HIV; Osteopenia; Osteoporosis; HIV Infections

NCT ID: NCT00939874

Cell Phone Intervention to Support Antiretroviral Therapy (ART) Adherence in Kenya

Condition: HIV; AIDS; HIV Infections

NCT ID: NCT00830622

Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00099671

Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-Related Weight Loss

Condition: HIV Infections; Unintended Weight Loss; Cachexia; Anorexia; AIDS Wasting Syndrome; HIV Wasting Syndrome

NCT ID: NCT00637572

A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen

Condition: HIV Infections

NCT ID: NCT00135395

Treatment of Oral Warts in HIV+ Patients

Condition: Papillomatosis; HIV Infections

NCT ID: NCT00454181

ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla

Condition: HIV Infections

NCT ID: NCT00615745

Treatment of Abnormal Adipose Tissue Accumulation in HIV Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00082628

Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)

Condition: HIV Infections

NCT ID: NCT00113282

Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients

Condition: HIV Infections; Acquired Immune Deficiency Syndrome

NCT ID: NCT00055185

An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients

Condition: HIV Infection

NCT ID: NCT00189930

ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.

Condition: HIV Infections

NCT ID: NCT00461266

Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+

Condition: Fibromyalgia; HIV-1 Infection

NCT ID: NCT00552682

Human Atherosclerotic Plaque Inflammation Imaged Using PDG-PET/CT

Condition: Insulin Resistance; Atherosclerosis; Cardiovascular Disease; HIV/AIDS; HIV Infections

NCT ID: NCT00958815

Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC

Condition: HIV Infection; HIV Infections

NCT ID: NCT00865475

Preliminary Study of Safety and Efficacy of Policosanol

Condition: HIV-Related Dyslipidemia; HIV Infections

NCT ID: NCT00312923

Effective Aids Treatment and Support in the Free State (FEATS)

Condition: HIV/AIDS; Food Insecurity; HIV Infections

NCT ID: NCT00821366

Lopinavir/Ritonavir (Kaletra) PK in Children

Condition: HIV/AIDS Treatment; HIV Infections

NCT ID: NCT00810108

Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication

Condition: Chronic Hepatitis C; HIV Infections

NCT ID: NCT00296972

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

Condition: HIV Infections

NCT ID: NCT00027339

Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00050063

An Electronic Pillbox for People With HIV

Condition: HIV Infections

NCT ID: NCT00071500

Cardiovascular Prevention for Persons With HIV

Condition: HIV Infection; Cardiovascular Disease Risk

NCT ID: NCT00982189

Durability of Adherence in Self-Management of HIV (The DASH Study)

Condition: HIV Infections

NCT ID: NCT00991302

A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00033163

Zinc Therapy in HIV Infected Individuals Who Abuse Drugs

Condition: HIV Infections; Substance-Related Disorders

NCT ID: NCT00149552

Handheld Computers to Improve Adherence to Anti-HIV Drug Regimens

Condition: HIV Infections

NCT ID: NCT00053443

Directly Observed Therapy for HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00259389

Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral Density

Condition: HIV Infections; Osteopenia; Osteoporosis

NCT ID: NCT00102908

Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People

Condition: HIV Infections

NCT ID: NCT00053430

Blood Levels of Abacavir in HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00087945

Metabolic Abnormalities in HIV Infected and Uninfected Young Women

Condition: HIV Infections; Hypercholesterolemia; Glucose Intolerance

NCT ID: NCT00067587

Psychiatric Problems in Children and Adolescents Infected With HIV at Birth

Condition: HIV Infections; Mental Disorders

NCT ID: NCT00100542

Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV

Condition: HIV Infections

NCT ID: NCT00084058

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

Condition: HIV Infections

NCT ID: NCT00659789

A Trial of PEHRG214 in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00385567

Directly Observed Therapy in HIV Infected Adolescent Focus Groups

Condition: HIV Infections

NCT ID: NCT00079729

Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults

Condition: HIV Infections; Lipodystrophy; Diabetes; Hyperlipidemia; Atherosclerosis

NCT ID: NCT00331448

Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials

Condition: HIV Infections

NCT ID: NCT00514098

Capravirine to Treat Children With HIV Infection

Condition: HIV Infection

NCT ID: NCT00006519

Long-term Follow-up of HIV Infected Patients Identified During Early Infection

Condition: HIV Infections

NCT ID: NCT00086372

Treatment Plan to Decrease Drug Exposure in HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00067574

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

Condition: HIV Infections

NCT ID: NCT00102986

Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00393276

Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy

Condition: HIV Infections; Lipoatrophy

NCT ID: NCT00307164

Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00073424

Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults

Condition: HIV Infections

NCT ID: NCT00361257

Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia

Condition: HIV Infections; Hyperlipidemia

NCT ID: NCT00663234

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women

Condition: HIV Infections; Pregnancy

NCT ID: NCT00125983

A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00476424

Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation

Condition: HIV Infections

NCT ID: NCT00447902

Optimal Treatment for Kidney Disease in HIV Infected Adults

Condition: HIV Infections; Kidney Disease

NCT ID: NCT00089518

Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents

Condition: HIV Infections; Influenza

NCT ID: NCT00091702

Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)

Condition: HIV Infections; Sexually Transmitted Diseases

NCT ID: NCT00146419

Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients

Condition: HIV Infections; Hypercholesterolemia; Hypertriglyceridemia; Diabetes Mellitus

NCT ID: NCT00046267

Switching From PI to RALtegravir in HIV Stable Patients

Condition: HIV Infections

NCT ID: NCT00528892

Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring

Condition: Human Immunodeficiency Virus; HIV Infections

NCT ID: NCT00836212

Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in co-Infected HIV/HCV Patients

Condition: HIV Infections

NCT ID: NCT00661349

Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response

Condition: HIV Infections

NCT ID: NCT00518154

Vitamin D Reabsorption in Adolescents and Young Adults With HIV Infection

Condition: HIV Infections

NCT ID: NCT00490412

The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00061256

Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis C; Liver Disease

NCT ID: NCT00078403

NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission

Condition: HIV Infections

NCT ID: NCT00089505

Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection

Condition: HIV Infections

NCT ID: NCT00059462

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen

Condition: HIV Infection

NCT ID: NCT00443729

Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults

Condition: HIV Infections

NCT ID: NCT00099684

Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People

Condition: HIV Infections

NCT ID: NCT00078442

A Cluster-Randomized Intervention Trial to Improve Quality of Life for HIV-Infected Individuals in Anhui, China

Condition: HIV Infections

NCT ID: NCT00479141

Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals

Condition: HIV Infections

NCT ID: NCT00272493

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT00120393

Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00470210

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

Condition: HIV Infections

NCT ID: NCT00001131

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)

Condition: HIV Infection

NCT ID: NCT00443703

Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children

Condition: HIV Infections

NCT ID: NCT00312091

Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune

Condition: HIV Infections

NCT ID: NCT00979420

INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.

Condition: HIV Infections

NCT ID: NCT00615134

Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand

Condition: HIV Infections

NCT ID: NCT00672412

Pilot Assessment of Lopinavir/Ritonavir and Maraviroc

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00981318

Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance

Condition: HIV Infections

NCT ID: NCT00187551

A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019 EXT2)

Condition: HIV Infections

NCT ID: NCT00293254

A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)

Condition: HIV Infections

NCT ID: NCT00293267

Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment

Condition: Human Immunodeficiency Virus; Ischemic Heart Disease

NCT ID: NCT00296153

QoL and Adherence to One-pill Once-a-day HAART

Condition: HIV Infection; HIV Infections

NCT ID: NCT00990600

Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy

Condition: HIV Infection; Lipodystrophy; HIV Infections

NCT ID: NCT00865007

Raltegravir Switch for Toxicity or Adverse Events

Condition: HIV/AIDS; Antiretroviral Therapy; HIV Infections

NCT ID: NCT00958100

Effect of Extra Virgin Olive Oil on Atherosclerosis Biomarkers in HIV-infected Patients

Condition: HIV; Atherosclerosis; HIV Infections

NCT ID: NCT00925795

HIV Antiretroviral Drugs and Metabolism

Condition: HIV Infections

NCT ID: NCT00525239

Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients

Condition: HIV Infections; Lipodystrophy; Wasting Disease

NCT ID: NCT00028314

Raltegravir Therapy for Women With HIV and Fat Accumulation

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00656175

Effects of L-Carnitine on Postprandial Clearance of Triglyceride-Rich Lipoproteins in HIV Patients on HAART

Condition: Hyperlipidemia; HIV Infections

NCT ID: NCT00386971

Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment

Condition: HIV Infections

NCT ID: NCT00012519

A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to Raltegravir

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00950859

Raltegravir Intensification in HIV-infected Patients

Condition: HIV Infections

NCT ID: NCT00631449

Effects of Anti-HIV Therapy on Nervous System Function

Condition: HIV Infections

NCT ID: NCT00432003

A Study of Anal Cancer Development in HIV Infected People

Condition: HIV Infections; Anus Neoplasms

NCT ID: NCT00107679

Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIV

Condition: HIV

NCT ID: NCT00295477

A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males

Condition: HIV Infections

NCT ID: NCT00040300

A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment

Condition: HIV Infections

NCT ID: NCT00145795

Effect of Interleukin-2 on HIV Treatment Interruption

Condition: HIV Infections

NCT ID: NCT00015704

Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients

Condition: HIV Infections

NCT ID: NCT00390780

Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients

Condition: HIV

NCT ID: NCT00299091

Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection

Condition: HIV Infections

NCT ID: NCT00050284

Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)

Condition: Hyperlipidemia; HIV Infections

NCT ID: NCT00117494

CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery

Condition: HIV Infections

NCT ID: NCT00925756

A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy

Condition: HIV Infections

NCT ID: NCT00067782

The St. Marys and The Mater Switch Study

Condition: HIV Infections

NCT ID: NCT00981773

Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults

Condition: HIV Infections

NCT ID: NCT00449436

Integrase Inhibitor (MK-0518) Viral Decay

Condition: HIV Infections

NCT ID: NCT00520897

Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine

Condition: HIV Infections; Insulin Resistance; Hyperlactatemia

NCT ID: NCT00471614

Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children

Condition: HIV Infections

NCT ID: NCT00260078

Comparison of Liquid Kaletra and Low Dose Kaletra Tablets

Condition: HIV Infections

NCT ID: NCT00762320

A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1

Condition: HIV-1

NCT ID: NCT00824369

Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease

Condition: HIV Infections; Heart Disease

NCT ID: NCT01001767

Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only

Condition: HIV Infections

NCT ID: NCT00415090

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT00273273

Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAART

Condition: HIV

NCT ID: NCT00516581

Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products

Condition: HIV Infections

NCT ID: NCT00455585

IL-7 Receptor Polymorphisms and Immune Recovery With HAART

Condition: HIV Infections

NCT ID: NCT00168207

Fosamprenavir Expanded Access

Condition: HIV Infection

NCT ID: NCT00240552

Double Protease Inhibitor to Darunavir Switch Study

Condition: HIV Infections

NCT ID: NCT00531557

RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00157027

Evaluation of Atazanavir Substitution Intervention (EASI) Study

Condition: HIV Infections

NCT ID: NCT00247845

Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular Route

Condition: Healthy Volunteers; HIV Infection

NCT ID: NCT00261001

Phase I/II, Open-Label Trial of Three Monoclonal Antibodies

Condition: HIV Infections

NCT ID: NCT00219986

Pediatric Expanded Access Program-Oral Solution

Condition: HIV Infections

NCT ID: NCT00543530

Raltegravir and Atazanavir Dosing Strategy Study

Condition: HIV Infection

NCT ID: NCT00874523

Effect of Rosuvastatin on Endothelial Function

Condition: HIV Infections; Cardiovascular Disease

NCT ID: NCT00986999

Combination of Efavirenz and Truvada - COMET Study

Condition: HIV Infections

NCT ID: NCT00224458

Kaletra-isentress Treatment Evaluation

Condition: HIV Infections

NCT ID: NCT00700115

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00426296

Lopinavir Capsules to Kaletra or Invirase Tablets

Condition: HIV Infections

NCT ID: NCT00438152

Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART

Condition: HIV Infections

NCT ID: NCT00270205

Tenofovir DF + Efavirenz (TDF+EFV) Versus Tenofovir DF + Efavirenz + Lamivudine (TDF+EFV+3TC) Maintenance Regimen in Virologically Controlled Patients: COOL Trial

Condition: HIV Infections

NCT ID: NCT00643968

ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial

Condition: HIV Infections

NCT ID: NCT00615810

PREventing Progression of Adipose Tissue Redistribution

Condition: HIV Infections

NCT ID: NCT00389194

Testosterone and Physical Function in HIV+ Men

Condition: HIV Associate Weight Loss

NCT ID: NCT00260143

Multicenter, Safety Study Of Maraviroc

Condition: Acquired Immunodeficiency Syndrome; HIV Infection

NCT ID: NCT00478231

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.

Condition: HIV Infections

NCT ID: NCT00040157

TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients

Condition: Anti-Retroviral Agents; HIV-1

NCT ID: NCT00412646

Study to Evaluate Switching From Regimens Consisting of Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed Dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

Condition: HIV-1 Infection

NCT ID: NCT01252940

Study to Evaluate Switching From a Regimen Consisting of a Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) to Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate STR

Condition: HIV-1 Infection

NCT ID: NCT01286740

Study of Raltegravir Versus Nucleotide Reverse Transcriptase Inhibitors (NRTIs) as a Backbone in HIV-Infected Subjects Switched From a Stable Boosted Protease Inhibitor (PI) Regimen

Condition: HIV Infections

NCT ID: NCT00717964

A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India

Condition: Human Immunodeficiency Virus (HIV)

NCT ID: NCT00992654

A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1

Condition: HIV-1

NCT ID: NCT00823979

Evaluation and Monitoring of Patients With HIV Infectionn

Condition: HIV

NCT ID: NCT00557570

Promoting Adherence to Anti-HIV Drug Regimens

Condition: HIV Infections

NCT ID: NCT00051805

BASTA Study on STI in HIV Infected Patients

Condition: HIV Infection

NCT ID: NCT00310245

Alternative Dosing Strategy for Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00059384

Atazanavir for HIV Infected Individuals: An Early Access Program

Condition: HIV Infections

NCT ID: NCT00046345

Metabolic Effects of Non-Thymidine Analogue Anti-HIV Medications

Condition: HIV Infections

NCT ID: NCT00433992

Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2

Condition: HIV Infections; Hepatitis A; Hepatitis B

NCT ID: NCT00451984

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00068809

Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy

Condition: HIV Infections

NCT ID: NCT00357552

Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects

Condition: HIV Infection

NCT ID: NCT00096746

Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants

Condition: HIV Infections

NCT ID: NCT00385632

Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00466180

A Phase 2 Study Of PF-00232798 In HIV Positive Patients

Condition: HIV

NCT ID: NCT00495677

Switching From Protease Inhibitor (PI) to Etravirine in HIV-1 Infected Subjects With Viremia Suppression

Condition: HIV

NCT ID: NCT01034917

Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load

Condition: HIV Infections

NCT ID: NCT00515827

Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)(COMPLETED)

Condition: HIV Infections

NCT ID: NCT00705419

Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study

Condition: HIV Infection; Hyperlipidemia

NCT ID: NCT00225017

The Maraviroc Central Nervous System (CNS) Study

Condition: HIV Infections

NCT ID: NCT00982878

Cohort Study for Patients Using Fuzeon (Enfuvirtide)

Condition: HIV Infections; Antiretroviral Treatment

NCT ID: NCT00216359

A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses

Condition: HIV Infections

NCT ID: NCT00001108

Dose Reduction of Lopinavir in Children

Condition: HIV Infections

NCT ID: NCT00887120

Problems With Immune Recovery in the Gut Tissue

Condition: Human Immunodeficiency Virus

NCT ID: NCT01460433

Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring

Condition: Acquired Immunodeficiency Syndrome; Resistance

NCT ID: NCT00434070

Therapeutic Approaches to HAART-Induced Lipodystrophy

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00461552

Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting

Condition: Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting; HIV Infections

NCT ID: NCT00642499

Long-Term Data Collection From Participants in Adult AIDS Clinical Trials

Condition: HIV Infections

NCT ID: NCT00001137

Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.

Condition: HIV

NCT ID: NCT00460746

Adherence-Suppression-Resistance Relationships for Atripla Compared to Historical Antiretroviral Regimens

Condition: HIV Infections; Adherence

NCT ID: NCT01006005

Switch to Darunavir/r + Maraviroc QD in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)

Condition: HIV Infection

NCT ID: NCT01367210

Managing Medications

Condition: HIV Infections

NCT ID: NCT00222716

BRAVO: Background Regimen of Raltegravir on Virologic Outcome

Condition: HIV Infections

NCT ID: NCT00751530

Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r

Condition: HIV Infections

NCT ID: NCT00756730

A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study

Condition: HIV Infections

NCT ID: NCT00192634

Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens

Condition: HIV Infections

NCT ID: NCT00994344

Metabolic Effects of Switching Kaletra to Boosted Reyataz

Condition: HIV Infections

NCT ID: NCT00413153

Patient Preference, Sleep Quality, and Anxiety/Depression: A Comparison of Raltegravir and Efavirenz

Condition: Sleep Disorders; HIV Infections

NCT ID: NCT00944957

The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens

Condition: HIV Infections

NCT ID: NCT00152061

Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)

Condition: HIV Infections

NCT ID: NCT00312169

Directly Observed Therapy in High Risk Populations in Newark, NJ

Condition: Directly Observed Therapy; HIV Infections

NCT ID: NCT00285883

High-Dose Chemotherapy With Transplantation of Gene-Modified Stem Cells for High-Risk AIDS-Related Lymphoma

Condition: AIDS-Related Lymphoma; HIV Infections

NCT ID: NCT00858793

ADHEPTA Study: Adherence Questionnaire in Hepatitis C

Condition: Hepatitis C, Chronic; HIV Infection

NCT ID: NCT00998621

VENICE Study Nevirapine Full Dose/Dose Escalation

Condition: HIV Infections

NCT ID: NCT00704249

CCRC: A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Raltegravir Therapy

Condition: HIV Infections; AIDS

NCT ID: NCT00661960

Artery Elasticity After Switch From Epzicom to Truvada

Condition: HIV Infections

NCT ID: NCT00998582

Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors

Condition: HIV Infections

NCT ID: NCT00543101

FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment

Condition: HIV Infections

NCT ID: NCT00414635

Study of Once Daily Elvucitabine Versus Lamivudine in Subjects With a Documented M184V Mutation

Condition: HIV Infections

NCT ID: NCT00312039

A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen

Condition: HIV Infections

NCT ID: NCT00135447

Kaletra Sex/Gender Pharmacokinetics (PK) Study: A Switch From Twice Daily to Once Daily Lopinavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT00148759

Maraviroc Immune Recovery Study

Condition: HIV Infections

NCT ID: NCT00875368

2NN & CHARM Long-Term Follow-up Study

Condition: HIV Infections

NCT ID: NCT00127972

Atazanavir and Lamivudine for Treatment Simplification

Condition: HIV Infections

NCT ID: NCT00885482

BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)

Condition: HIV Infections

NCT ID: NCT00414284

Simplification From Protease Inhibitors to Raltegravir

Condition: HIV Infections

NCT ID: NCT00941083

China Adherence for Life

Condition: HIV Infections

NCT ID: NCT00661258

Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression

Condition: HIV Infection

NCT ID: NCT00787774

An Open-label Trial With TMC125 in Patients Who Have Virologically Failed in a DUET Trial (TMC125-C206 or TMC125-C216).

Condition: HIV-1

NCT ID: NCT00359021

Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285)(TERMINATED)

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00243568

A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults

Condition: Infection, Human Immunodeficiency Virus I; HIV-1 Infection

NCT ID: NCT00242879

Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children

Condition: HIV Infections

NCT ID: NCT00528957

Lopinavir/Ritonavir Monotherapy in Children

Condition: HIV Infections

NCT ID: NCT00626301

Pharmacokinetics of Low Dose Ritonavir

Condition: HIV Infections

NCT ID: NCT00622206

Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression

Condition: HIV Infections

NCT ID: NCT00709111

A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102

Condition: HIV Infections

NCT ID: NCT00048217

The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections; Hypertriglyceridemia

NCT ID: NCT00076518

Atazanavir/Ritonavir Maintenance Therapy

Condition: HIV Infections

NCT ID: NCT00084019

Antihyperlipidemic Effects of Oyster Mushrooms

Condition: HIV Infections; Hyperlipidemia

NCT ID: NCT00069524

Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission

Condition: HIV Infections; Pregnancy Complications, Infectious

NCT ID: NCT00028145

Lopinavir/r Monotherapy as Maintenance Therapy After Long Term Viral Suppression

Condition: HIV Infections

NCT ID: NCT00160849

Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment

Condition: HIV Infections

NCT ID: NCT00751153

Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults

Condition: HIV Infections

NCT ID: NCT00977756

Collection of Blood Samples From SMART Study Participants for Future Genetic Studies

Condition: HIV Infections

NCT ID: NCT00377169

Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy

Condition: HIV Infections; Peripheral Nervous System Diseases

NCT ID: NCT00050271

SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function

Condition: HIV Infection

NCT ID: NCT00225082

Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc

Condition: HIV Infections

NCT ID: NCT00703586

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Condition: HIV Infections

NCT ID: NCT00042289

Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access

Condition: HIV

NCT ID: NCT01003990

A Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 Trial

Condition: HIV Infections

NCT ID: NCT00622232

Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART.

Condition: HIV

NCT ID: NCT00270556

Dolutegravir Expanded Access Study

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01536873

Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV

Condition: HIV Infections

NCT ID: NCT00035932

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Condition: HIV Infections

NCT ID: NCT00102960

Extending HIV Care Beyond the Rural Health Center

Condition: HIV; HIV Infections

NCT ID: NCT00371540

Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults

Condition: HIV Infections

NCT ID: NCT00608569

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects

Condition: Hepatitis C,; Human Immunodeficiency Virus

NCT ID: NCT01667731

Pilot Study of Maraviroc/Raltegravir for Naive HIV-1 Patients

Condition: HIV

NCT ID: NCT01291459

Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)

Condition: HIV Infections

NCT ID: NCT00144170

Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients

Condition: HIV-2 Infection

NCT ID: NCT01605890

Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma

Condition: Lymphoma

NCT ID: NCT00641381

Strategies for Delivering Anti-HIV Therapy in South Africa

Condition: HIV Infections

NCT ID: NCT00080522

Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00428116

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00427297

Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)

Condition: HIV Infections

NCT ID: NCT00054717

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00098722

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00098306

Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY

Condition: HIV

NCT ID: NCT00235222

Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals

Condition: HIV Infection

NCT ID: NCT01433289

Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma

Condition: AIDS-Related Primary Central Nervous System Lymphoma; HIV

NCT ID: NCT00267865

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

Condition: Kaposi's Sarcoma

NCT ID: NCT00686842

HIV Viral Load Monitoring in Resource-Poor Settings

Condition: HIV; AIDS; HIV Infections

NCT ID: NCT00929604

Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875AM5)(COMPLETED)

Condition: HIV Infections

NCT ID: NCT00551018

Multi-vitamins, HAART and HIV/AIDS in Uganda

Condition: HIV/AIDS

NCT ID: NCT01228578

A Study of the Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With HIV-1

Condition: HIV Infection

NCT ID: NCT01717287

The VMVN Study: Virological Monitoring in Viet Nam

Condition: HIV Infection; AIDS

NCT ID: NCT01317498

Assessment of the Effectiveness of New Clinical Guidelines for Differential Diagnosis and Management of Common HIV/AIDS-related Conditions in Mozambique

Condition: Anemia; Fever; HIV Positive

NCT ID: NCT01681914

Effect of Repeated Exposures to Compressed Air on Patients With AIDS

Condition: AIDS

NCT ID: NCT00444847

EuroSIDA As An External Comparator To MOTIVATE Trials

Condition: HIV; AIDS

NCT ID: NCT01329783

A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients

Condition: Human Immunodeficiency Virus-Type 1

NCT ID: NCT01726348

A Trial of Vitamins and HAART in HIV Disease Progression

Condition: HIV Infections

NCT ID: NCT00383669

The Mochudi Prevention Project ART Protocol

Condition: HIV Infections

NCT ID: NCT01583439

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00001087

Investigator-Sponsored Protocol - Continued Use of Ibalizumab

Condition: HIV Infections

NCT ID: NCT01056393

Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT00619944

Maraviroc Compassionate Use

Condition: Human Immunodeficiency Virus Type 1

NCT ID: NCT00719823

Safety and Effectiveness of World Health Organization Dosing Guidelines of Lopinavir/Ritonavir for Children

Condition: HIV

NCT ID: NCT01172535

Chinese Network of Pediatric Antiretroviral Therapy

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT01210924

Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT01482767

Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma

Condition: Lymphoma

NCT ID: NCT00569985

Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz

Condition: HIV Infections

NCT ID: NCT01160120

To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine

Condition: AIDS

NCT ID: NCT00207168

Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China.

Condition: AIDS

NCT ID: NCT01344148

Antiretroviral Drug Levels During and After Pregnancy

Condition: Pharmacokinetics

NCT ID: NCT00616252

Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma

Condition: AIDS-related Kaposi Sarcoma; Classic Kaposi Sarcoma

NCT ID: NCT00521092